J14/H12 recombinant peptide subunit vaccine (QIMR) | Interleukin Related interleukin-related.com

Product Name :
J14/H12 recombinant peptide subunit vaccine (QIMR)

Search keywords :
J14

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Immunostimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Qimr Berghofer Medical Research Institute

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Streptococcal Infections

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IL-8/CXCL8 Antibody In Vitro
Met (C-Met) Rabbit mAb site
FKBP51 Antibody: FKBP51 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to FKBP51. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts